The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against <i>Mycobacterium abscessus</i> Infections

The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against <i>Mycobacterium abscessus</i> Infections

Peroxisome proliferator-activated receptor α (PPARα) shows promising potential to enhance host defenses against <i>Mycobacterium tuberculosis</i> infection. Herein we evaluated the protective effect of PPARα against nontuberculous mycobacterial (NTM) infections...

Full description

Bibliographic Details
Main Authors:	Yi Sak Kim, Jin Kyung Kim, Bui Thi Bich Hanh, Soo Yeon Kim, Hyeon Ji Kim, Young Jae Kim, Sang Min Jeon, Cho Rong Park, Goo Taeg Oh, June-Woo Park, Jin-Man Kim, Jichan Jang, Eun-Kyeong Jo
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Cells
Subjects:	pparα <i>mycobacterium abscessus</i> gemfibrozil tfeb inflammation
Online Access:	https://www.mdpi.com/2073-4409/9/3/648

Similar Items

Etamycin as a Novel <i>Mycobacterium abscessus</i> Inhibitor
by: Bui Thi Bich Hanh, et al.
Published: (2020-09-01)

Rifamycin O, An Alternative Anti-<i>Mycobacterium abscessus</i> Agent
by: Bui Thi Bich Hanh, et al.
Published: (2020-03-01)

A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against <i>Mycobacterium abscessus</i>
by: Taeho Kim, et al.
Published: (2021-05-01)

Gemfibrozil Induces Anemia, Leukopenia and Reduces Hematopoietic Stem Cells via PPAR-α in Mice
by: Gabriel Rufino Estrela, et al.
Published: (2020-07-01)

Ameliorative potential of gemfibrozil and silymarin on experimentally induced nephrotoxicity in rats
by: A.M. Kabel, et al.
Published: (2013-12-01)

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
by: Bui Thi Bich Hanh, et al.
Published: (2021-12-01)

Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil
by: William S. Mohan, et al.
Published: (1998-02-01)

Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against <i>Mycobacterium abscessus</i>
by: Da-Gyum Lee, et al.
Published: (2021-10-01)

Effects of Fenofibrate and Gemfibrozil on Kynurenic Acid Production in Rat Kidneys In Vitro: Old Drugs, New Properties
by: Izabela Zakrocka, et al.
Published: (2023-11-01)

Pravastatin and Gemfibrozil Modulate Differently Hepatic and Colonic Mitochondrial Respiration in Tissue Homogenates from Healthy Rats
by: Anna Herminghaus, et al.
Published: (2019-08-01)

Analysis of in vitro and in vivo metabolism of zidovudine and gemfibrozil in trans‐chromosomic mouse line expressing human UGT2 enzymes
by: Kaoru Kobayashi, et al.
Published: (2022-12-01)

Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells
by: Cornel Manuel Bachmann, et al.
Published: (2023-02-01)

Effects of Milk Thistle, Artichoke and Olive Extracts in Comparison with Atorvastatin and Gemfibrozil on Liver Function in Broiler Chicken
by: Tavakolinasab F, et al.
Published: (2020-05-01)

Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
by: Nguyen Thanh Quang, et al.
Published: (2021-08-01)

Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil
by: Stefano Liberi, et al.
Published: (2022-02-01)

Alternative and Experimental Therapies of <i>Mycobacterium abscessus</i> Infections
by: Michal Meir, et al.
Published: (2020-09-01)

Ohmyungsamycin promotes M1-like inflammatory responses to enhance host defence against Mycobacteroides abscessus infections
by: Sang Min Jeon, et al.
Published: (2022-12-01)

Atypical Mycobacteriosis Due to <i>Mycobacterium abscessus</i> subsp. <i>massiliense</i>: Our Experince
by: Carmen Rodríguez-Cerdeira, et al.
Published: (2022-11-01)

Gemfibrozil Improves Microcirculatory Oxygenation of Colon and Liver without Affecting Mitochondrial Function in a Model of Abdominal Sepsis in Rats
by: Anne Kuebart, et al.
Published: (2023-12-01)

10-DEBC Hydrochloride as a Promising New Agent against Infection of <i>Mycobacterium abscessus</i>
by: Da-Gyum Lee, et al.
Published: (2022-01-01)

An Overview of the Applications of Gemfibrozil Nano-Formulation in Hyperlipidemia
by: Kiran Patel, et al.
Published: (2023-05-01)

Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to <i>Mycobacterium abscessus</i> Infections
by: Fabian Schnitker, et al.
Published: (2023-09-01)

Rapid and Accurate Discrimination of <i>Mycobacterium abscessus</i> Subspecies Based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Spectrum and Machine Learning Algorithms
by: Hsin-Yao Wang, et al.
Published: (2022-12-01)

Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α
by: Sumita Raha, et al.
Published: (2023-12-01)

Development and Validation for Quantitative Determination of Genotoxic Impurity in Gemfibrozil by Gas Chromatography with Mass Spectrometry
by: Hari Naga Prasada Reddy Chittireddy, et al.
Published: (2023-02-01)

Rifampicin–Liposomes for <i>Mycobacterium abscessus</i> Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation
by: Federica Rinaldi, et al.
Published: (2021-07-01)

<i>Mycobacterium abscessus</i>: It’s Complex
by: Hazem F. M. Abdelaal, et al.
Published: (2022-07-01)

Type I Interferons Are Involved in the Intracellular Growth Control of Mycobacterium abscessus by Mediating NOD2-Induced Production of Nitric Oxide in Macrophages
by: Jae-Hun Ahn, et al.
Published: (2021-10-01)

Moles of Molecules against <i>Mycobacterium abscessus</i>: A Review of Current Research
by: Mario Cocorullo, et al.
Published: (2023-09-01)

Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report
by: Chamara Dalugama, et al.
Published: (2018-05-01)

A New Model of Chronic <i>Mycobacterium abscessus</i> Lung Infection in Immunocompetent Mice
by: Camilla Riva, et al.
Published: (2020-09-01)

Single Cell Analysis of Drug Susceptibility of <i>Mycobacterium abscessus</i> during Macrophage Infection
by: Joanna Brzostek, et al.
Published: (2020-10-01)

Updated Review on the Mechanisms of Pathogenicity in <i>Mycobacterium abscessus</i>, a Rapidly Growing Emerging Pathogen
by: Paula López-Roa, et al.
Published: (2022-12-01)

Postoperative Mycobacteroides abscessus subsp. abscessus endophthalmitis: Clinical analysis of 12 clustered adults and a proposed therapeutic algorithm
by: Jia-Horung Hung, et al.
Published: (2020-10-01)

Activity of Oritavancin and Its Synergy with Other Antibiotics against <i>Mycobacterium abscessus</i> Infection In Vitro and In Vivo
by: Gaoyan Wang, et al.
Published: (2021-06-01)

Activity of Drug Combinations against <i>Mycobacterium abscessus</i> Grown in Aerobic and Hypoxic Conditions
by: Alessio Lanni, et al.
Published: (2022-07-01)

2-Aminoimidazoles Inhibit <i>Mycobacterium abscessus</i> Biofilms in a Zinc-Dependent Manner
by: Juan M. Belardinelli, et al.
Published: (2022-03-01)

Phage Therapy for Mycobacterium Abscessus and Strategies to Improve Outcomes
by: Abdolrazagh Hashemi Shahraki, et al.
Published: (2021-03-01)

An Artefactual Cluster of <i>Mycobacterium abscessus</i> Pneumonia among Cancer Patients Arising from Contamination
by: Giusy Diella, et al.
Published: (2022-01-01)

Distinct Effects of Moxifloxacin and Bedaquiline on Growing and ‘Non-Culturable’ <i>Mycobacterium abscessus</i>
by: Andrey L. Mulyukin, et al.
Published: (2023-11-01)